CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 149 filers reported holding CARA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $961,466 | +302.3% | 195,818 | +647.0% | 0.00% | +300.0% |
| Q2 2022 | $239,000 | +35.8% | 26,215 | +81.4% | 0.00% | – |
| Q4 2021 | $176,000 | -12.4% | 14,449 | +11.1% | 0.00% | -100.0% |
| Q3 2021 | $201,000 | -13.4% | 13,000 | +21.9% | 0.00% | 0.0% |
| Q1 2021 | $232,000 | -41.6% | 10,664 | -65.9% | 0.00% | -80.0% |
| Q3 2020 | $397,000 | +168.2% | 31,231 | +179.0% | 0.01% | +25.0% |
| Q1 2020 | $148,000 | -78.3% | 11,195 | -73.5% | 0.00% | 0.0% |
| Q4 2019 | $681,000 | +258.4% | 42,254 | +306.4% | 0.00% | +100.0% |
| Q3 2019 | $190,000 | -19.1% | 10,397 | +6.2% | 0.00% | -33.3% |
| Q3 2018 | $235,000 | -78.3% | 9,794 | -88.9% | 0.00% | -84.2% |
| Q4 2017 | $1,084,000 | +32.2% | 88,566 | +0.3% | 0.02% | -44.1% |
| Q4 2016 | $820,000 | – | 88,279 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chescapmanager LLC | 1,655,576 | $4,685,280 | 0.73% |
| Bain Capital Life Sciences Investors, LLC | 934,898 | $2,645,761 | 0.27% |
| FNY Investment Advisers, LLC | 35,000 | $99 | 0.12% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,764,201 | $4,992,689 | 0.11% |
| Ergoteles LLC | 358,275 | $1,013,918 | 0.05% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 84,530 | $239,220 | 0.04% |
| PDT Partners, LLC | 85,088 | $240,799 | 0.03% |
| PINNACLE ASSOCIATES LTD | 672,440 | $1,903,005 | 0.03% |
| Alpine Global Management, LLC | 34,014 | $96,260 | 0.03% |
| XTX Topco Ltd | 52,025 | $147,231 | 0.03% |